FAST Italy Hosts Its First Scientific Symposium on Angelman Syndrome
FAST Italy’s first-ever Scientific Symposium drew over 100 attendees and unveiled two new biotech companies, MavriX Bio and CourageAS Bio, advancing gene therapies for Angelman syndrome.